Mankind Pharma Ltd.

NSE: MANKIND | BSE: 543904 | ISIN: INE634S01028 | Industry: Pharmaceuticals
| Expensive Performer
2164.6000 -31.90 (-1.45%)
NSE Jan 01, 2026 15:31 PM
Volume: 85,103
 

2164.60
-1.45%
Asit C Mehta Investment Interrmediates
Mankind benefits from the industry experience and business acumen of their individual Promoters and is driven by the 3 core values of quality, affordability and accessibility. Their professional and experienced management team has been critical in building their brands, growing their operations, and maintaining capital efficiency despite their emphasis on affordable product offerings.
BP Wealth released a Buy report for Mankind Pharma Ltd. with a price target of 2652.0 on 16 Dec, 2025.
More from Mankind Pharma Ltd.
Recommended